Related Experiment Video
Updated: Apr 27, 2026

Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
Hemostatic profile in healthy premature neonates; does birth weight affect the coagulation profile?
Alireza Abdollahi1, Sara Sheikhbahaei1, Nima Hafezi-Nejad1
1Department of Pathology, Imam Hospital Complex, Thrombosis and Hemostasis Research Center, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Context:
There are limited studies assessing the neonatal hemostatic factors in relation to birth weight.
Aims:
This study aims to compare the coagulation factors between three groups of neonates with different birth weight for gestational age (GA).
Settings And Design:
In a cross-sectional study, 74 healthy premature neonates were involved.
Subjects And Methods:
Serum prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), thrombin clotting time (TT), and levels of fibrinogen, anti-thrombin III, protein S and protein C were measured. Neonates were classified into three groups according to birth weight, including small, appropriate and large for gestational age (SGA, AGA, and LGA).
Statistical Analysis Used:
Statistical analysis was performed using SPSS software.
Results:
There was a significant difference in the levels of protein S (P < 0.001), protein C (P = 0.004), and values of APTT (P = 0.01) between three groups. Other coagulation factors however, did not represent a significant pattern (P > 0.05). Protein S concentration, directly (B = 0.78, P < 0.001), and APTT, inversely (B = -0.29, P = 0.03), associated with birth weight after adjustment for GA and sex.
Conclusions:
Despite the decrease in APTT from SGA to AGA, and LGA neonates, levels of protein S increases directly with birth weight. However, no other coagulation factors revealed an explainable pattern in relation to the state of SGA, AGA, or LGA.
More Related Videos
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...

